(XAR) SPDR S&P Aerospace & Defense - Ratings and Ratios
Aerospace, Defense, Equities, Sampling, Index
Dividends
| Dividend Yield | 0.46% |
| Yield on Cost 5y | 0.82% |
| Yield CAGR 5y | -0.36% |
| Payout Consistency | 86.7% |
| Payout Ratio | - |
| Risk via 5d forecast | |
|---|---|
| Volatility | 28.1% |
| Value at Risk 5%th | 46.1% |
| Relative Tail Risk | -0.29% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.00 |
| Alpha | 48.47 |
| CAGR/Max DD | 1.81 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.450 |
| Beta | 1.004 |
| Beta Downside | 0.949 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.73% |
| Mean DD | 3.46% |
| Median DD | 2.66% |
Description: XAR SPDR S&P Aerospace & Defense January 10, 2026
The SPDR® S&P Aerospace & Defense ETF (ticker XAR) aims to replicate the S&P Aerospace & Defense Select Industry Index by using a sampling methodology, allocating at least 80 % of its assets to the index constituents. The index captures the aerospace and defense slice of the broader S&P Total Market Index, providing exposure to U.S.-based industrial firms in these sectors.
Key industry drivers to watch include: (1) U.S. defense appropriations, which topped $800 billion in FY 2024 and set a baseline for government contract revenue; (2) commercial aircraft backlog levels, currently hovering around 4,000 units worldwide, indicating future demand for airframe manufacturers; and (3) R&D intensity, with top defense firms averaging 6–8 % of sales on research, a metric that often predicts long-term competitive advantage.
For a deeper quantitative assessment, consider exploring ValueRay’s sector analytics to complement this overview.
What is the price of XAR shares?
Over the past week, the price has changed by +7.90%, over one month by +18.74%, over three months by +15.21% and over the past year by +69.89%.
Is XAR a buy, sell or hold?
What are the forecasts/targets for the XAR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 377 | 34.2% |
XAR Fundamental Data Overview January 10, 2026
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 5.10b USD (5.10b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 5.10b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 5.10b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.62% (E(5.10b)/V(5.10b) * Re(9.62%) + (debt-free company))
Discount Rate = 9.62% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for XAR ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle